beta-lactams has been researched along with salicylates in 2 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (salicylates) | Trials (salicylates) | Recent Studies (post-2010) (salicylates) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 13,317 | 853 | 1,678 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amicosante, G; Becerro, P; Casañas, L; Jiménez de Anta, MT; Perilli, M; Tavío, MM; Vila, J | 1 |
| Amicosante, G; Becerro, P; De Anta, MT; Perilli, M; Ruiz, J; Tavío, MM; Vila, J | 1 |
2 other study(ies) available for beta-lactams and salicylates
| Article | Year |
|---|---|
Salicylate decreases production of AmpC type beta-lactamases and increases susceptibility to beta-lactams in a Morganella morganii clinical isolate.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Inpatients; Microbial Sensitivity Tests; Morganella morganii; Nalidixic Acid; Norfloxacin; Salicylates; Tetracycline; Urine | 2004 |
Ciprofloxacin, salicylate, and 2,4-dinitrophenol decrease production of AmpC-type beta-lactamase in two Citrobacter freundii clinical isolates.
Topics: 2,4-Dinitrophenol; beta-Lactamases; beta-Lactams; Ciprofloxacin; Citrobacter freundii; Drug Resistance, Bacterial; Enzyme Induction; Humans; Salicylates | 2005 |